The CBD oil product has been successful in lowering levels of the stress hormone cortisol in horses being transported.
The study was conducted at Tarleton University, a member of the Texas A&M University System, on a commercial product made by HempMy Pet.
CBD, or cannabidiol, is non-intoxicating and one of the many phytochemicals found in cannabis Factory.
Tarleton used the company’s Full Spectrum Abacus CBD oil on horses to determine if it had a role in mediating stressors, decreasing the risk of injury during transport and handling, and decreasing overstimulation of the pituitary and adrenal glands, commonly called the HPA axis.
Research has shown that higher doses of CBD (0.6 mg per kg of body weight) were generally more effective compared to lower doses of CBD (.3 mg per kg of body weight).
At both doses, CBD was undetectable 24 hours later, with peak blood concentration levels peaking four hours after the dose was administered.
No difference in the effects of cannabidiol was observed in male and female horses, but there was an increase in feed intake times at both low and high CBD doses. It is observed that the higher dose has a much longer feeding time compared to the lower dose.
The research showed a decrease in levels of the stress hormone cortisol in the transport portion of the study, and that there were no long-term effects of CBD at either dose level.
Environmental stressors such as handling, transportation, and housing can affect aspects of a horse’s behavior, such as weight gain and feeding efficiency, as well as motivate stereotypical behaviors, such as bar biting, self-mutilation, and excessive aggression.
CBD has been shown to reduce anxiety from a variety of stimuli in previous studies of both dogs and mice, and researchers were excited to see similar results with horses.
Dr. Kimberly Guay, assistant professor in the Tarleton Department of Equine Sciences, has been investigating the use of CBD in animals, including horses. “My research goals are to undertake as many projects as necessary to better understand the physiological and behavioral responses of animals when they consume CBD and cannabis byproduct processing products such as hemp seed meal.
“It is important to recognize the differences in these products so that we can classify and use them in safe and beneficial ways.
“There is still a lot to be done, and we will continue to fill in the remaining voids regarding these products in our animals.”
Guay praised HempMy Pet for making what she described as a responsible and conscious decision to subject their products to unbiased analysis.
HempMy Pet co-founder and chief operating officer, Natalie Munden, said Tarleton’s work was the company’s second clinical trial, but the first to be performed on horses. She said the company was pleased with the results.
“Approaching Tarleton University to collaborate on a study was very exciting for us, as it shows that interest in the therapeutic benefits of cannabis is valid and has a real future in medicine.
“If we look at the science and the data behind all the research that has been done to date, it is impossible to ignore that CBD and cannabis derivatives have an overwhelmingly positive impact on a myriad of health concerns and are a real alternative to medication.”
HempMy Pet offers CBD-infused products for dogs, cats, and horses. All are made from their own full-spectrum indoor oil grown in Colorado greenhouses.